AU783841B2 - Nucleic acid probe arrays - Google Patents

Nucleic acid probe arrays Download PDF

Info

Publication number
AU783841B2
AU783841B2 AU17927/01A AU1792701A AU783841B2 AU 783841 B2 AU783841 B2 AU 783841B2 AU 17927/01 A AU17927/01 A AU 17927/01A AU 1792701 A AU1792701 A AU 1792701A AU 783841 B2 AU783841 B2 AU 783841B2
Authority
AU
Australia
Prior art keywords
region
nucleic acid
target nucleic
anchor
oligonucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU17927/01A
Other languages
English (en)
Other versions
AU1792701A (en
Inventor
Joel S. Bader
Jonathan M. Rothberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
454 Life Science Corp
Original Assignee
CuraGen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CuraGen Corp filed Critical CuraGen Corp
Publication of AU1792701A publication Critical patent/AU1792701A/en
Application granted granted Critical
Publication of AU783841B2 publication Critical patent/AU783841B2/en
Assigned to 454 LIFE SCIENCES CORPORATION reassignment 454 LIFE SCIENCES CORPORATION Alteration of Name(s) in Register under S187 Assignors: CURAGEN CORPORATION
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/682—Signal amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Nanotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Composite Materials (AREA)
  • Biophysics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AU17927/01A 1999-11-26 2000-11-27 Nucleic acid probe arrays Ceased AU783841B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44940299A 1999-11-26 1999-11-26
US09/449402 1999-11-26
PCT/US2000/032131 WO2001038580A2 (en) 1999-11-26 2000-11-27 Nucleic acid probe arrays

Publications (2)

Publication Number Publication Date
AU1792701A AU1792701A (en) 2001-06-04
AU783841B2 true AU783841B2 (en) 2005-12-15

Family

ID=23784034

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17927/01A Ceased AU783841B2 (en) 1999-11-26 2000-11-27 Nucleic acid probe arrays

Country Status (5)

Country Link
EP (1) EP1234058A2 (de)
JP (1) JP2003515149A (de)
AU (1) AU783841B2 (de)
CA (1) CA2392474A1 (de)
WO (1) WO2001038580A2 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2378245A (en) 2001-08-03 2003-02-05 Mats Nilsson Nucleic acid amplification method
US9388459B2 (en) * 2002-06-17 2016-07-12 Affymetrix, Inc. Methods for genotyping
US9487823B2 (en) 2002-12-20 2016-11-08 Qiagen Gmbh Nucleic acid amplification
US6977153B2 (en) * 2002-12-31 2005-12-20 Qiagen Gmbh Rolling circle amplification of RNA
EP1598427A1 (de) * 2004-05-17 2005-11-23 Charité - Universitätsmedizin Berlin Verfahren zur Amplifikation eines Nukleinsäurezielmoleküls
EP2471923B1 (de) 2004-05-28 2014-08-20 Asuragen, Inc. Verfahren und Zusammensetzungen mit microRNA
ES2503765T3 (es) 2004-11-12 2014-10-07 Asuragen, Inc. Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN
CA2611671C (en) 2005-06-15 2013-10-08 Callida Genomics, Inc. Single molecule arrays for genetic and chemical analysis
EP1762627A1 (de) 2005-09-09 2007-03-14 Qiagen GmbH Verfahren zur Aktivierung einer Nukleinsäure für eine Polymerase-Reaktion
US11306351B2 (en) 2005-12-21 2022-04-19 Affymetrix, Inc. Methods for genotyping
US20090131348A1 (en) 2006-09-19 2009-05-21 Emmanuel Labourier Micrornas differentially expressed in pancreatic diseases and uses thereof
AU2007299748A1 (en) 2006-09-19 2008-03-27 Asuragen, Inc. miR-15, miR-26, miR -31,miR -145, miR-147, miR-188, miR-215, miR-216 miR-331, mmu-miR-292-3p regulated genes and pathways as targets for therapeutic intervention
JP5719591B2 (ja) 2007-06-08 2015-05-20 バイオジェン アイデック エムエー インコーポレイティドＢｉｏｇｅｎ Ｉｄｅｃ Ｉｎｃ． 抗ｔｎｆ応答性または非応答性を予測するためのバイオマーカー
JP5020734B2 (ja) * 2007-07-31 2012-09-05 株式会社日立ハイテクノロジーズ 核酸解析方法及び装置
US8258111B2 (en) 2008-05-08 2012-09-04 The Johns Hopkins University Compositions and methods related to miRNA modulation of neovascularization or angiogenesis
US8486630B2 (en) * 2008-11-07 2013-07-16 Industrial Technology Research Institute Methods for accurate sequence data and modified base position determination
GB0921264D0 (en) 2009-12-03 2010-01-20 Olink Genomics Ab Method for amplification of target nucleic acid
US10273544B2 (en) 2010-02-11 2019-04-30 Dana-Farber Cancer Institute, Inc. Methods for predicting likelihood of responding to treatment
ES2631458T3 (es) 2010-03-04 2017-08-31 Interna Technologies B.V. Molécula de ARNmi definida por su fuente y sus usos terapéuticos en el cáncer asociado a la EMT
WO2012005572A1 (en) 2010-07-06 2012-01-12 Interna Technologies Bv Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway
US10150999B2 (en) 2010-11-17 2018-12-11 Interpace Diagnostics, Llc miRNAs as biomarkers for distinguishing benign from malignant thyroid neoplasms
EP2474617A1 (de) 2011-01-11 2012-07-11 InteRNA Technologies BV MIR zur Behandlung von Neoangiogenese
US20140057295A1 (en) 2011-02-28 2014-02-27 Barbara J. Stegmann Anti-mullerian hormone changes in pregnancy and prediction of adverse pregnancy outcomes and gender
CN102732598B (zh) * 2011-04-11 2017-03-01 陈先锋 一种全基因组dna序列拼接测序方法
CN103582887B (zh) 2011-06-07 2017-07-04 皇家飞利浦有限公司 提供核苷酸序列数据的方法和测序装置
WO2013040251A2 (en) 2011-09-13 2013-03-21 Asurgen, Inc. Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease
WO2013063519A1 (en) 2011-10-26 2013-05-02 Asuragen, Inc. Methods and compositions involving mirna expression levels for distinguishing pancreatic cysts
EP2771487A1 (de) 2011-10-27 2014-09-03 Asuragen, INC. Mirnas als diagnostische biomarker zur unterscheidung gutartiger von bösartigen tumoren in der schilddrüse
EP2870263A1 (de) 2012-07-03 2015-05-13 InteRNA Technologies B.V. Diagnoseportfolio und dessen verwendungen
WO2014055117A1 (en) 2012-10-04 2014-04-10 Asuragen, Inc. Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions
KR101984700B1 (ko) * 2012-11-19 2019-05-31 삼성전자주식회사 폴리뉴클레오티드 및 그의 용도
CA2905949A1 (en) 2013-03-15 2014-09-25 Baylor Research Institute Ulcerative colitis (uc)-associated colorectal neoplasia markers
CA2907377A1 (en) 2013-03-15 2014-09-18 Baylor Research Institute Tissue and blood-based mirna biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer
EP3404116B1 (de) 2013-03-15 2022-10-19 The University of Chicago Verfahren und zusammensetzungen in zusammenhang mit t-zell aktivität
US11859246B2 (en) * 2013-12-11 2024-01-02 Accuragen Holdings Limited Methods and compositions for enrichment of amplification products
US11286519B2 (en) 2013-12-11 2022-03-29 Accuragen Holdings Limited Methods and compositions for enrichment of amplification products
EP3495506B1 (de) * 2013-12-11 2023-07-12 AccuraGen Holdings Limited Verfahren zum nachweis seltener sequenzvarianten
EP3277836B1 (de) 2015-04-02 2019-02-27 HMNC Value GmbH Behandlungsverfahren unter verwendung von genetischen prädiktoren einer reaktion auf eine behandlung mit ssr-125543
JP7008016B2 (ja) 2015-10-09 2022-01-25 アキュラジェン ホールディングス リミテッド 増幅産生物の富化のための方法および組成物
JPWO2017135383A1 (ja) * 2016-02-03 2018-12-06 国立大学法人豊橋技術科学大学 偽環状二重鎖ポリヌクレオチドと、それを用いた遺伝子発現阻害剤
US11427866B2 (en) 2016-05-16 2022-08-30 Accuragen Holdings Limited Method of improved sequencing by strand identification
JP6966052B2 (ja) 2016-08-15 2021-11-10 アキュラーゲン ホールディングス リミテッド 稀な配列変異体を検出するための組成物および方法
WO2018094031A1 (en) * 2016-11-16 2018-05-24 Progenity, Inc. Multimodal assay for detecting nucleic acid aberrations
US11497762B2 (en) 2017-11-03 2022-11-15 Interna Technologies B.V. MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation
US11203782B2 (en) 2018-03-29 2021-12-21 Accuragen Holdings Limited Compositions and methods comprising asymmetric barcoding
US12049665B2 (en) 2018-06-12 2024-07-30 Accuragen Holdings Limited Methods and compositions for forming ligation products
JP7566775B2 (ja) 2019-04-12 2024-10-15 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 筋肉量及び酸化的代謝を増加させるための組成物及び方法
WO2024028794A1 (en) 2022-08-02 2024-02-08 Temple Therapeutics BV Methods for treating endometrial and ovarian hyperproliferative disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5503980A (en) * 1992-11-06 1996-04-02 Trustees Of Boston University Positional sequencing by hybridization
US5854033A (en) * 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
SE9701783D0 (sv) * 1997-05-14 1997-05-14 Marek Kwiatkowski In situ synthesis of oligonucleotides of inverse orientation
US6280954B1 (en) * 1998-02-02 2001-08-28 Amersham Pharmacia Biotech Ab Arrayed primer extension technique for nucleic acid analysis
AU3601599A (en) * 1998-03-25 1999-10-18 Ulf Landegren Rolling circle replication of padlock probes
AU3567099A (en) * 1998-04-16 1999-11-01 Packard Bioscience Company Analysis of polynucleotide sequence

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HATCH, A. ET AL (1999) GENETIC ANALYSIS:BIOMOL ENG. 15:35-40 *

Also Published As

Publication number Publication date
WO2001038580A3 (en) 2002-04-25
AU1792701A (en) 2001-06-04
WO2001038580A2 (en) 2001-05-31
WO2001038580A9 (en) 2002-12-05
CA2392474A1 (en) 2001-05-31
JP2003515149A (ja) 2003-04-22
EP1234058A2 (de) 2002-08-28

Similar Documents

Publication Publication Date Title
AU783841B2 (en) Nucleic acid probe arrays
JP5957039B2 (ja) 全ゲノム増幅および遺伝型決定のための方法および組成物
US6355431B1 (en) Detection of nucleic acid amplification reactions using bead arrays
US6376191B1 (en) Microarray-based analysis of polynucleotide sequence variations
EP0754240B1 (de) Ligase/polymerase-vermittelte analyse genetischer elemente von einzelnukleotid-polymorphismen und ihre verwendung in der genetischen analyse
JP4216333B2 (ja) オリゴヌクレオチドの化学結合による核酸検出及び増幅
US20050074787A1 (en) Universal arrays
US20050037393A1 (en) Methods and compositions for whole genome amplification and genotyping
US20050191636A1 (en) Detection of STRP, such as fragile X syndrome
CA2295996A1 (en) High-throughput screening method for identification of genetic mutations or disease-causing microorganisms using segmented primers
US7262032B2 (en) Allele-specific mutation detection assay using an enzyme-disabling agent
Nilsson et al. Making ends meet in genetic analysis using padlock probes
JP2001054400A (ja) 遺伝子型決定二対立遺伝子マーカー
US20100285970A1 (en) Methods of sequencing nucleic acids
EP1606389B1 (de) Verfahren zum nachweis von polynukleotidsequenzen
WO2000009738A9 (en) Rolling circle-based analysis of polynucleotide sequence
US20060003360A1 (en) Method for analyzing variation of nucleic acid and method for analyzing gene expression
US20040203005A1 (en) Dual hybridization of complex nucleic acid samples for sequencing and single-nucleotide polymorphism identification
Banér Genetic Analyses using Rolling Circle or PCR Amplified Padlock Probes